RxSight: After Dropping To The Bottom, It's Time To Pick It Up

RxSight, Inc. exhibits quantitative similarities to other small caps that I have rated here on Seeking Alpha that strongly outperformed the market. RXST is an 'NCAV' opportunity, a company that sells for less than its current asset value even though management is putting the company back on the growth track. My thesis is grounded in historical patterns where cash-rich, loss-making small caps often resolve operational issues before exhausting reserves. It's crucial to diversify when buying into these types of equities.

RxSight Demonstrates Similarities With A Peer Group That Returned Over 300% I have rated several small caps here on Seeking Alpha that—at the time of their rating—shared certain quantitative similarities. These issues have performed very well